Ophthalmologist perceptions regarding treatment of moderate to severe dry eye: results of a physician survey.
about
Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye diseaseModulation of HLA-DR in dry eye patients following 30 days of treatment with a lubricant eyedrop solution.Expert opinion in the management of aqueous Deficient Dry Eye Disease (DED).Lifitegrast: A novel drug for treatment of dry eye disease.
P2860
Ophthalmologist perceptions regarding treatment of moderate to severe dry eye: results of a physician survey.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Ophthalmologist perceptions re ...... results of a physician survey.
@ast
Ophthalmologist perceptions re ...... results of a physician survey.
@en
type
label
Ophthalmologist perceptions re ...... results of a physician survey.
@ast
Ophthalmologist perceptions re ...... results of a physician survey.
@en
prefLabel
Ophthalmologist perceptions re ...... results of a physician survey.
@ast
Ophthalmologist perceptions re ...... results of a physician survey.
@en
P1476
Ophthalmologist perceptions re ...... results of a physician survey
@en
P2093
Penny A Asbell
Scott Spiegel
P2860
P304
P577
2009-12-01T00:00:00Z